Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for CIP of Chromatography Skids – V 2.0

Posted on By


Biosimilars: SOP for CIP of Chromatography Skids – V 2.0


Standard Operating Procedure for Cleaning-In-Place (CIP) of Chromatography Skids in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/168/2025
Supersedes SOP/BS/168/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for validated cleaning-in-place (CIP) of chromatography skids used in biosimilar manufacturing, ensuring effective residue removal and equipment readiness for subsequent purification campaigns under GMP.

2. Scope

This SOP is applicable to all multi-use chromatography skids and systems equipped with integrated valves, sensors, pumps, and tubing that come in contact with biosimilar intermediates or buffers.

3. Responsibilities

  • Production: Perform CIP process and document execution.
  • QA: Review and verify cleaning logs, visual inspection, and cleaning validation parameters.
  • Engineering: Maintain CIP programming, skid calibration, and preventive maintenance.

4. Accountability

The Downstream Processing Manager is accountable for ensuring the chromatography skid is cleaned, verified, and released before reuse in any production lot.

5. Procedure

5.1 Pre-Cleaning Check

  1. Ensure the system has completed its last purification cycle and is disconnected from the column.
  2. Visually inspect for product spills, leaks, or material residues. Record findings in Annexure-1.
  3. Verify availability of validated cleaning solutions and filters.

5.2 CIP Setup

  1. Connect CIP tanks to the skid inlet and outlet lines.
  2. Ensure skid valves, pump, and pH/conductivity sensors are operational.
  3. Load cleaning solution:
    • Cleaning agent: 0.5 M NaOH or 2% NaOH (as per validation)
    • Neutralizer (if required): 1 M acetic acid

5.3 Execution of CIP Cycle

  1. Step 1: Pre-rinse with WFI – 1 CV at 100 cm/hr
  2. Step 2: Circulate 0.5 M NaOH – 2 CV for 30 min at 25–30°C
  3. Step 3: Intermediate rinse with WFI – until neutral pH is achieved
  4. Step 4: Optional neutralization rinse (if acid is used)
  5. Step 5: Final rinse with WFI – continue until conductivity < 1.3 µS/cm

5.4 Post-CIP Evaluation

  1. Record rinse pH and conductivity of last three samples.
  2. Perform visual inspection for any discoloration, leaks, or residue.
  3. Attach rinse analysis reports in Annexure-2.

5.5 Cleaning Verification

  1. Conduct TOC test and residue-specific swab (if applicable) after every fifth cycle.
  2. Record TOC values (limit < 500 ppb) and file in Annexure-3.

5.6 Documentation

  1. Complete CIP logbook entries for each cycle with date, time, operator, and solution volumes.
  2. Ensure QA release and affix “CLEANED AND READY” status tag on skid panel.

6. Abbreviations

  • CIP: Clean-In-Place
  • TOC: Total Organic Carbon
  • CV: Column Volume
  • WFI: Water for Injection

7. Documents

  1. Visual Inspection Checklist – Annexure-1
  2. Rinse Verification Report – Annexure-2
  3. TOC and Residue Test Log – Annexure-3

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • WHO TRS 999 – GMP for Biotherapeutic Products
  • OEM Cleaning Recommendations (Cytiva ÄKTA, Repligen Skids)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Visual Inspection Checklist

Skid ID Inspection Date Observed Issue Status Operator
SKD-DSP-01 04/05/2025 None Acceptable Ajay Verma

Annexure-2: Rinse Verification Report

Sample No. pH Conductivity (µS/cm) Result Verified By
1 6.7 1.1 Pass Sunita Reddy

Annexure-3: TOC and Residue Test Log

Date Skid ID TOC Result (ppb) Swab Test Status QA Reviewer
04/05/2025 SKD-DSP-01 395 Negative Acceptable Vinay Pawar

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added TOC and conductivity criteria for rinse validation QA audit requirement
See also  Biosimilars: SOP for Tangential Flow Filtration (TFF) Skid Operation - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Troubleshooting Electrical Failures in Machines – V 2.0
Next Post: Gel Manufacturing: SOP for Cleaning of HVAC Filters in Gel Production Area – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version